analyst
PT
NASDAQ · PTCT
PTC Therapeutics, Inc.
Healthcare · Biotechnology
$65.65
Up+$1.94 (+2.96%)
Updated Sep 16, 2026, 8:04 PM
SID Score
5.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 6.05B
- P/E ratio
- 7.87
- Dividend yield
- 0.00%
- 52-week range
- $57.74 – $90.87
- Volume
- 1.03M
- Avg. volume
- 1.55M
Price performance
PTCT price history
1M range · 20 trading sessions · Daily adjusted prices
PTCT closed at $65.65 after 20 trading sessions, down 9.61% for the selected period.
- Last close
- $65.65
- Period change
- -9.61%
- Period low
- $65.65
- Period high
- $73.67
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $66.51 | $66.54 | $65.06 | $65.65 | 1.03M |
| Sep 14, 2026 | $67.09 | $67.99 | $65.91 | $66.48 | 1.02M |
| Sep 11, 2026 | $67.80 | $68.48 | $65.91 | $66.06 | 792.89K |
| Sep 10, 2026 | $66.84 | $67.78 | $66.47 | $67.37 | 1.01M |
| Sep 9, 2026 | $68.08 | $68.84 | $67.50 | $67.57 | 1.07M |
| Sep 8, 2026 | $67.81 | $70.08 | $67.475 | $68.81 | 1.12M |
| Sep 4, 2026 | $70.62 | $71.405 | $69.26 | $69.30 | 673.54K |
| Sep 3, 2026 | $71.76 | $71.97 | $70.55 | $71.40 | 654.52K |
| Sep 2, 2026 | $71.15 | $72.68 | $69.835 | $71.79 | 902.58K |
| Sep 1, 2026 | $69.42 | $70.84 | $69.05 | $70.56 | 691.02K |
| Aug 31, 2026 | $69.98 | $70.42 | $68.755 | $69.54 | 841.1K |
| Aug 28, 2026 | $71.08 | $71.49 | $69.61 | $70.09 | 692.68K |
| Aug 27, 2026 | $72.11 | $72.66 | $70.91 | $71.81 | 746.33K |
| Aug 26, 2026 | $73.18 | $73.525 | $71.81 | $72.69 | 533.67K |
| Aug 25, 2026 | $71.69 | $73.47 | $71.69 | $73.47 | 624.46K |
| Aug 24, 2026 | $69.67 | $71.45 | $68.02 | $71.06 | 897.68K |
| Aug 21, 2026 | $70.54 | $71.36 | $69.79 | $69.82 | 674.74K |
| Aug 20, 2026 | $73.05 | $73.56 | $70.46 | $70.52 | 802.51K |
| Aug 19, 2026 | $73.72 | $74.02 | $72.215 | $73.67 | 1.51M |
| Aug 18, 2026 | $72.86 | $74.03 | $72.225 | $72.63 | 731.63K |
Latest PTCT news
The latest Smart Investors Daily articles mentioning PTCT.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…